Improving MRI techniques for better heart imaging in children and adults with congenital heart disease.
Fast and Accurate Cardiovascular MRI with Hyper 4D-Flow
This study is testing a new MRI technique called 4D-Flow MRI to help doctors better understand blood flow in people with congenital heart disease, making it easier and faster to monitor heart health and plan treatments for both kids and adults.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11004026 on NIH RePORTER |
What this research studies
This research focuses on developing a new magnetic resonance imaging (MRI) method called 4D-Flow MRI to assess blood flow dynamics in patients with congenital heart disease (CHD). The goal is to enhance the accuracy and speed of MRI exams, which are crucial for monitoring heart function and planning surgeries in both pediatric and adult patients. By addressing current limitations in pediatric imaging, such as long acquisition times and poor image quality, this project aims to provide a more effective tool for clinicians. Patients will benefit from improved diagnostic capabilities that can lead to better treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include children and adults diagnosed with congenital heart disease who require regular cardiovascular imaging.
Not a fit: Patients without congenital heart disease or those who do not require MRI for heart assessment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate heart imaging, improving care for patients with congenital heart disease.
How similar studies have performed: Previous research has shown promise in improving MRI techniques for cardiovascular assessment, indicating potential for success in this novel approach.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Ennis, Daniel B — Stanford University
- Study coordinator: Ennis, Daniel B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.